168 related articles for article (PubMed ID: 36398357)
1. The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics.
Hishe HZ; Stocker SL; Stamp LK; Dalbeth N; Merriman TR; Phipps-Green A; Wright DFB
Clin Transl Sci; 2023 Mar; 16(3):422-428. PubMed ID: 36398357
[TBL] [Abstract][Full Text] [Related]
2. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics, pharmacodynamics and pharmacogenetics modelling of oxypurinol in Hmong adults with gout and/or hyperuricemia.
Wen YF; Brundage RC; Roman YM; Culhane-Pera KA; Straka RJ
Br J Clin Pharmacol; 2023 Oct; 89(10):2964-2976. PubMed ID: 37202871
[TBL] [Abstract][Full Text] [Related]
4. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
Hurba O; Mancikova A; Krylov V; Pavlikova M; Pavelka K; Stibůrková B
PLoS One; 2014; 9(9):e107902. PubMed ID: 25268603
[TBL] [Abstract][Full Text] [Related]
5. Tubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary uric acid excretion.
Torres RJ; de Miguel E; Bailén R; Banegas JR; Puig JG
J Rheumatol; 2014 Sep; 41(9):1863-70. PubMed ID: 25128519
[TBL] [Abstract][Full Text] [Related]
6. Examining the Association of Rare Allelic Variants in Urate Transporters
Vávra J; Pavelcová K; Mašínová J; Hasíková L; Bubeníková E; Urbanová A; Mančíková A; Stibůrková B
Dis Markers; 2024; 2024():5930566. PubMed ID: 38222853
[TBL] [Abstract][Full Text] [Related]
7. Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects.
Flynn TJ; Phipps-Green A; Hollis-Moffatt JE; Merriman ME; Topless R; Montgomery G; Chapman B; Stamp LK; Dalbeth N; Merriman TR
Arthritis Res Ther; 2013; 15(6):R220. PubMed ID: 24360580
[TBL] [Abstract][Full Text] [Related]
8. Variants of ALPK1 with ABCG2, SLC2A9, and SLC22A12 increased the positive predictive value for gout.
Tu HP; Min-Shan Ko A; Lee SS; Lee CP; Kuo TM; Huang CM; Ko YC
J Hum Genet; 2018 Jan; 63(1):63-70. PubMed ID: 29215084
[TBL] [Abstract][Full Text] [Related]
9. The genetics of hyperuricaemia and gout.
Reginato AM; Mount DB; Yang I; Choi HK
Nat Rev Rheumatol; 2012 Oct; 8(10):610-21. PubMed ID: 22945592
[TBL] [Abstract][Full Text] [Related]
10. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.
Iwanaga T; Kobayashi D; Hirayama M; Maeda T; Tamai I
Drug Metab Dispos; 2005 Dec; 33(12):1791-5. PubMed ID: 16135657
[TBL] [Abstract][Full Text] [Related]
11. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
Liu J; Yang W; Li Y; Wei Z; Dan X
BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2.
Mancikova A; Krylov V; Hurba O; Sebesta I; Nakamura M; Ichida K; Stiburkova B
Clin Exp Nephrol; 2016 Aug; 20(4):578-584. PubMed ID: 26500098
[TBL] [Abstract][Full Text] [Related]
13. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
Anzai N; Ichida K; Jutabha P; Kimura T; Babu E; Jin CJ; Srivastava S; Kitamura K; Hisatome I; Endou H; Sakurai H
J Biol Chem; 2008 Oct; 283(40):26834-8. PubMed ID: 18701466
[TBL] [Abstract][Full Text] [Related]
14. GLUT9 as a potential drug target for chronic kidney disease: Drug target validation by a Mendelian randomization study.
Ueda M; Fukui K; Kamatani N; Kamitsuji S; Matsuo A; Sasase T; Nishiu J; Matsushita M
J Hum Genet; 2023 Oct; 68(10):699-704. PubMed ID: 37308567
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in GCKR, SLC17A1 and SLC22A12 were associated with phenotype gout in Han Chinese males: a case-control study.
Zhou ZW; Cui LL; Han L; Wang C; Song ZJ; Shen JW; Li ZQ; Chen JH; Wen ZJ; Wang XM; Shi YY; Li CG
BMC Med Genet; 2015 Aug; 16():66. PubMed ID: 26290326
[TBL] [Abstract][Full Text] [Related]
16. Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration.
Stamp LK; Chapman PT; Barclay M; Horne A; Frampton C; Merriman TR; Wright DFB; Drake J; Dalbeth N
Clin Transl Sci; 2020 Jan; 13(1):110-115. PubMed ID: 31444839
[TBL] [Abstract][Full Text] [Related]
17. An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites.
Pilon MO; Leclair G; Oussaïd E; St-Jean I; Jutras M; Gaulin MJ; Mongrain I; Busseuil D; Rouleau JL; Tardif JC; Dubé MP; de Denus S
Clin Transl Sci; 2022 Aug; 15(8):2024-2034. PubMed ID: 35689378
[TBL] [Abstract][Full Text] [Related]
18. Additive composite ABCG2, SLC2A9 and SLC22A12 scores of high-risk alleles with alcohol use modulate gout risk.
Tu HP; Chung CM; Min-Shan Ko A; Lee SS; Lai HM; Lee CH; Huang CM; Liu CS; Ko YC
J Hum Genet; 2016 Sep; 61(9):803-10. PubMed ID: 27225847
[TBL] [Abstract][Full Text] [Related]
19. Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling.
Bhatnagar V; Richard EL; Wu W; Nievergelt CM; Lipkowitz MS; Jeff J; Maihofer AX; Nigam SK
Clin Kidney J; 2016 Jun; 9(3):444-53. PubMed ID: 27274832
[TBL] [Abstract][Full Text] [Related]
20. The population pharmacokinetics of allopurinol and oxypurinol in patients with gout.
Wright DF; Stamp LK; Merriman TR; Barclay ML; Duffull SB; Holford NH
Eur J Clin Pharmacol; 2013 Jul; 69(7):1411-21. PubMed ID: 23475133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
